¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷) : 2021-08-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷) : 2021-08-28
±³À°ÀÏÀÚ : 2021-08-28
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : À±ÁöÇö
¿¬¶ôó : 070-4895-6129  
À̸ÞÀÏ : bmt@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-28 CA B 09:00~09:30 Autologous Stem Cell Transplantation for Aggressive B-cell Lymphomas in the Frontline Setting: Current Controversies and Advances  Narendranath Epperla(The Ohio State University Comprehensive Cancer Center) 
±³À°½Ã°£ 08-28 CA B 09:30~10:00 High Dose Therapy and Autologous Stem Cell Transplantation in Patients with Indolent Lymphoma  Julie M. Vose(University of Nebraska Medical Center) 
±³À°½Ã°£ 08-28 CA B 10:00~10:30 The Role of Allogeneic Stem Cell Transplantation for Relapsed and Refractory Lymphoma in the Era of CAR-T Cell Therapy  Youngwoo Jeon(The Catholic University of Korea) 
±³À°½Ã°£ 08-28 CA A 10:40~11:10 Prophylactic/preemptive DLI Real World Experience  Xiao jun Huang(Peking University Institute of Hematology) 
±³À°½Ã°£ 08-28 CA A 11:10~11:40 Therapeutic DLI in Relapsed/Refractory Hematologic Malignancy  Bhagirathbhai Dholaria(Vanderbilt University Medical Center) 
±³À°½Ã°£ 08-28 CA A 11:40~12:10 PTCY Based Haplo and DLI  Hyoung Jin Kang(Seoul National University College of Medicine) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Viirtual) - 8¿ù 28ÀÏ (3ÀÏÂ÷) : 2021-08-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀÌ°úÇÐȸ (¿Â¶óÀÎ) Á¦17ȸ ÀÓ»óÀÌ°úÇм¼¹Ì³ª : 2021-08-29
´ÙÀ½±Û (¿Â¶óÀÎ) 2021 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2021 Virtual) - 8¿ù 27ÀÏ (2ÀÏÂ÷) : 2021-08-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
660 Àü³² 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ±¤ÁÖÀü³²Áöȸ Áý´ãȸ : 2018-10-12 0 763 2018-08-29
659 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(¼±Ãµ°¢¸·È¥Å¹) : 2018-10-12 0 404 2018-08-29
658 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¸Á¸·ÁúȯÀÇ À¯ÀüÀÚ °Ë»ç) : 2018-10-12 0 961 2018-08-29
657 ¼­¿ï 2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference) : 2018-10-12 0 463 2018-08-29
656 °­¿ø 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-10-12 0 491 2018-08-29
655 °æ±â ±¹¸³¾Ï¼¾ÅÍ Á¦4Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-10-12 0 366 2018-08-29
654 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-10-12 0 371 2018-08-29
653 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) °¨¿° ÇǺÎÁúȯ 2) ÇǺΠºÎ¼Ó±â Áúȯ : 2018-10-11 0 551 2018-08-29
652 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ±Þ¿©±âÁØ°ú ½É»ç : 2018-10-11 0 595 2018-08-29
651 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-11 0 409 2018-08-29
650 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ÇÑÀÌȸ(Implant related dental sinusitis) : 2018-10-10 0 527 2018-08-29
649 °æ³² °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ¼­ºÎ°æ³² À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-10-10 0 562 2018-08-29
648 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç ¿ù·ÊÁý´ãȸ : 2018-10-10 0 545 2018-08-29
647 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-09 0 540 2018-08-29
646 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-08 0 562 2018-08-29
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷